Timothy Mastro, MD, DTM&HDirector, Global Health, Population and Nutrition
Areas of expertise
- HIV prevention, care and treatment research and programs
- Infectious diseases
- Global public health and development
- Clinical trials design and implementation
Dr. Timothy Mastro oversees FHI 360’s global research and technical work across a broad range of health, population and nutrition areas. Activities under his direction include global health research, global health programs, program sciences and technical support, nutrition and food security, contraceptive technology innovation and science facilitation.
Prior to joining FHI 360 in 2008, Mastro served for 20 years in scientific leadership positions at the U.S. Centers for Disease Control and Prevention (CDC). His research and work in programs at the Division of HIV/AIDS Prevention and Global AIDS Program addressed the prevention and treatment of HIV, sexually transmitted infections and tuberculosis. From 1993 to 2000, he served in Bangkok as director of the CDC-Thai Ministry of Health HIV/AIDS Collaboration.
Mastro has a bachelor’s degree in biology from Colgate University and a Doctor of Medicine from Saint Louis University. He trained in internal medicine at New York City’s Metropolitan Hospital and the Mount Sinai School of Medicine. He studied at the London School of Hygiene and Tropical Medicine and received a Diploma in Tropical Medicine and Hygiene from the Royal College of Physicians of London. Mastro is board certified in internal medicine, a fellow of the American College of Physicians and a member of the American Epidemiological Society. He received numerous awards at CDC and is the author or co-author of more than 160 published articles and book chapters.
Projects & Resources
In June 2014, the U.S. Agency for International Development awarded FHI 360 the Linkages across the Continuum of HIV Services for Key Populations Affected by HIV Project (LINKAGES), a five-year cooperative agreement funded by the U.S. President's Emergency Plan for AIDS Relief.
FHI 360 serves as the leadership and operations center for the HIV Prevention Trials Network (HPTN), a worldwide, collaborative, clinical trials network that develops and tests the safety and efficacy of primarily nonvaccine interventions to prevent the transmission of HIV.
This brief aims to inform program implementers and policymakers on the key issues faced by sex workers, what has worked in HIV prevention efforts with sex workers, and actions that can be taken to better meet the needs of sex workers in the future.
This brief seeks to help policymakers and program implementers understand and address the HIV needs and human rights of people who inject drugs.
This brief presents data from the 2014 GMHR describing access to HIV services among MSM and discusses the implications for strengthening the global HIV response.